Table 2.
Unadjusted and adjusted outcomes in different age-groups.
| Age in years | <50 | 50–64 | 65–74 | ≥75 |
|---|---|---|---|---|
| Number of patients | 474 | 1012 | 716 | 440 |
| In-hospital postoperative complications | ||||
| Total events (%) | 22 (4.6) | 29 (2.9) | 30 (4.2) | 30 (6.8) |
| unadj. analysis, OR (95% CI), P-value | Ref. | 0.61 (0.35–1.07), 0.083 | 0.90 (0.51–1.58), 0.709 | 1.50 (0.85–2.65), 0.158 |
| adj. analysisa, OR (95% CI), P-value | Ref. | 0.51 (0.28–0.92), 0.026 | 0.72 (0.39–1.33), 0.295 | 1.03 (0.54–1.95), 0.936 |
| ICU admissions | ||||
| Total events (%) | 9 (1.9) | 17 (1.7) | 15 (2.1) | 16 (3.6) |
| unadj. analysis, OR (95% CI), P-value | Ref. | 0.88 (0.39–2.00), 0.764 | 1.11 (0.48–2.55), 0.814 | 1.95 (0.85–4.46), 0.114 |
| adj. analysisa, OR (95% CI), P-value | Ref. | 0.91 (0.39–2.14), 0.832 | 1.06 (0.43–2.63), 0.894 | 1.48 (0.58–3.74), 0.413 |
| Unplanned all-cause 30-day-readmissions | ||||
| Total events (%) | 9 (1.9) | 22 (2.2) | 19 (2.7) | 21 (4.8) |
| unadj. analysis, OR (95% CI), P-value | Ref. | 1.15 (0.52–2.51), 0.73 | 1.41 (0.63–3.14), 0.402 | 2.59 (1.17–5.71), 0.019 |
| adj. analysisa, OR (95% CI), P-value | Ref. | 1.02 (0.45–2.28), 0.971 | 1.20 (0.51–2.82), 0.68 | 1.94 (0.81–4.61), 0.136 |
| Length of hospital stay > 3 days | ||||
| Total events (%) | 50 (10.6) | 114 (11.3) | 107 (14.9) | 125 (28.4) |
| unadj. analysis, OR (95% CI), P-value | Ref. | 1.08 (0.76–1.53), 0.681 | 1.49 (1.04–2.13), 0.029 | 3.37 (2.35–4.82), <0.001 |
| adj. analysisa, OR (95% CI), P-value | Ref. | 0.98 (0.67–1.43), 0.906 | 1.17 (0.78–1.75), 0.448 | 2.38 (1.57–3.60), <0.001 |
aAdjusted for gender, nationality, insurance status, date and type of admission, hospital size and teaching level, comorbidities, Charlson Comorbidity Index, Vitamin D deficiency and the presence of an end organ sequelae associated with primary hyperparathyroidism (osteoporosis, urolithiasis and/or renal insufficiency).
adj., adjusted; OR, odds ratio; Ref., reference; unadj., unadjusted.
This work is licensed under a